{"entity":{"type":"insider","cik":"0001464549","url":"/insider/0001464549","json_url":"/insider/0001464549.json","name":"Kim Jong Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":23,"first":"2011-06-20","last":"2021-02-03","span_basis":"filed_date"},"name_variants":[{"name":"Kim Jong Joseph","source":"filing","n_filings":23,"first_seen":"2011-06-20","last_seen":"2021-02-03"}],"transactions":[{"id":4713703,"accession":"0001055726-21-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-21-000008","line_url":"/filing/0001055726-21-000008#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62500.0,"shares_display":"62,500","price_per_share":14.24,"price_display":"14.24","price_state":"stated","total_value":890000.0,"total_display":"890,000.00","shares_owned_after":1078313.0,"shares_owned_after_display":"1,078,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-03","scope":"insider"},{"id":4713695,"accession":"0001055726-21-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-21-000008","line_url":"/filing/0001055726-21-000008#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","shares_owned_after":1078313.0,"shares_owned_after_display":"1,078,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":2556026,"accession":"0001055726-20-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-20-000045","line_url":"/filing/0001055726-20-000045#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":21.1345,"price_display":"21.13","price_state":"stated","total_value":2113450.0,"total_display":"2,113,450.00","shares_owned_after":1188313.0,"shares_owned_after_display":"1,188,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-30","filed_date":"2020-07-31","scope":"insider"},{"id":3036304,"accession":"0001055726-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-20-000002","line_url":"/filing/0001055726-20-000002#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22500.0,"shares_display":"22,500","price_per_share":3.11,"price_display":"3.11","price_state":"stated","total_value":69975.0,"total_display":"69,975.00","shares_owned_after":1100707.0,"shares_owned_after_display":"1,100,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-13","filed_date":"2020-01-13","scope":"insider"},{"id":7860034,"accession":"0001055726-19-000046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001055726-19-000046","line_url":"/filing/0001055726-19-000046#line-4","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":832848.0,"shares_display":"832,848","price_per_share":2.2987,"price_display":"2.30","price_state":"stated","total_value":1914467.6976,"total_display":"1,914,467.70","shares_owned_after":1078207.0,"shares_owned_after_display":"1,078,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-04","scope":"insider"},{"id":7860031,"accession":"0001055726-19-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-19-000046","line_url":"/filing/0001055726-19-000046#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":296705.0,"shares_display":"296,705","price_per_share":2.3078,"price_display":"2.31","price_state":"stated","total_value":684735.799,"total_display":"684,735.80","shares_owned_after":816527.0,"shares_owned_after_display":"816,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-04","scope":"insider"},{"id":7860024,"accession":"0001055726-19-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-19-000046","line_url":"/filing/0001055726-19-000046#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":2.4353,"price_display":"2.44","price_state":"stated","total_value":1217650.0,"total_display":"1,217,650.00","shares_owned_after":1911055.0,"shares_owned_after_display":"1,911,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-04","scope":"insider"},{"id":7860019,"accession":"0001055726-19-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-19-000046","line_url":"/filing/0001055726-19-000046#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":2.4016,"price_display":"2.40","price_state":"stated","total_value":1200800.0,"total_display":"1,200,800.00","shares_owned_after":1113232.0,"shares_owned_after_display":"1,113,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-04","scope":"insider"},{"id":8025989,"accession":"0001055726-19-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-19-000044","line_url":"/filing/0001055726-19-000044#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":3.31,"price_display":"3.31","price_state":"stated","total_value":331000.0,"total_display":"331,000.00","shares_owned_after":2411055.0,"shares_owned_after_display":"2,411,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-23","scope":"insider"},{"id":8025987,"accession":"0001055726-19-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-19-000042","line_url":"/filing/0001055726-19-000042#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61212.0,"shares_display":"61,212","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":214242.0,"total_display":"214,242.00","shares_owned_after":1613232.0,"shares_owned_after_display":"1,613,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-17","scope":"insider"},{"id":8025985,"accession":"0001055726-19-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-19-000042","line_url":"/filing/0001055726-19-000042#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75556.0,"shares_display":"75,556","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":264446.0,"total_display":"264,446.00","shares_owned_after":1674444.0,"shares_owned_after_display":"1,674,444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-17","scope":"insider"},{"id":6540115,"accession":"0001055726-18-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-18-000042","line_url":"/filing/0001055726-18-000042#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49060.0,"shares_display":"49,060","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":263452.2,"total_display":"263,452.20","shares_owned_after":2308494.0,"shares_owned_after_display":"2,308,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-14","scope":"insider"},{"id":6013708,"accession":"0001055726-18-000022","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001055726-18-000022","line_url":"/filing/0001055726-18-000022#line-4","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107500.0,"shares_display":"107,500","price_per_share":5.055,"price_display":"5.06","price_state":"stated","total_value":543412.5,"total_display":"543,412.50","shares_owned_after":2291807.0,"shares_owned_after_display":"2,291,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-13","filed_date":"2018-04-13","scope":"insider"},{"id":6013704,"accession":"0001055726-18-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-18-000022","line_url":"/filing/0001055726-18-000022#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103750.0,"shares_display":"103,750","price_per_share":5.1387,"price_display":"5.14","price_state":"stated","total_value":533140.125,"total_display":"533,140.12","shares_owned_after":2291807.0,"shares_owned_after_display":"2,291,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-12","filed_date":"2018-04-13","scope":"insider"},{"id":4844935,"accession":"0001055726-17-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001055726-17-000020","line_url":"/filing/0001055726-17-000020#line-4","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73590.0,"shares_display":"73,590","price_per_share":6.5739,"price_display":"6.57","price_state":"stated","total_value":483773.301,"total_display":"483,773.30","shares_owned_after":2091297.0,"shares_owned_after_display":"2,091,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-31","filed_date":"2017-04-03","scope":"insider"},{"id":4844923,"accession":"0001055726-17-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-17-000020","line_url":"/filing/0001055726-17-000020#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73590.0,"shares_display":"73,590","price_per_share":6.5051,"price_display":"6.51","price_state":"stated","total_value":478710.309,"total_display":"478,710.31","shares_owned_after":2091297.0,"shares_owned_after_display":"2,091,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-30","filed_date":"2017-04-03","scope":"insider"},{"id":6694344,"accession":"0001179110-14-012760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-012760","line_url":"/filing/0001179110-14-012760#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":9.055,"price_display":"9.06","price_state":"stated","total_value":2263750.0,"total_display":"2,263,750.00","shares_owned_after":1750000.0,"shares_owned_after_display":"1,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-12","scope":"insider"},{"id":6174920,"accession":"0001179110-14-006832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-006832","line_url":"/filing/0001179110-14-006832#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":56250.0,"total_display":"56,250.00","shares_owned_after":5965809.0,"shares_owned_after_display":"5,965,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-15","scope":"insider"},{"id":4905826,"accession":"0001179110-13-006143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-006143","line_url":"/filing/0001179110-13-006143#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":0.502,"price_display":"0.50","price_state":"stated","total_value":45180.0,"total_display":"45,180.00","shares_owned_after":11940809.0,"shares_owned_after_display":"11,940,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-02","filed_date":"2013-04-02","scope":"insider"},{"id":5386281,"accession":"0001179110-13-005520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-005520","line_url":"/filing/0001179110-13-005520#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":0.528,"price_display":"0.53","price_state":"stated","total_value":31680.0,"total_display":"31,680.00","shares_owned_after":11850809.0,"shares_owned_after_display":"11,850,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-20","filed_date":"2013-03-20","scope":"insider"},{"id":3221455,"accession":"0001179110-12-010179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-010179","line_url":"/filing/0001179110-12-010179#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.406,"price_display":"0.41","price_state":"stated","total_value":6090.0,"total_display":"6,090.00","shares_owned_after":11940809.0,"shares_owned_after_display":"11,940,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-13","filed_date":"2012-06-13","scope":"insider"},{"id":2378297,"accession":"0001179110-12-009705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-009705","line_url":"/filing/0001179110-12-009705#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":10250.0,"total_display":"10,250.00","shares_owned_after":11925809.0,"shares_owned_after_display":"11,925,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-05","filed_date":"2012-06-06","scope":"insider"},{"id":2678350,"accession":"0001179110-12-008185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-008185","line_url":"/filing/0001179110-12-008185#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.48,"price_display":"0.48","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","shares_owned_after":11900809.0,"shares_owned_after_display":"11,900,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-10","filed_date":"2012-05-10","scope":"insider"},{"id":2494767,"accession":"0001179110-12-005657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-12-005657","line_url":"/filing/0001179110-12-005657#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19116.0,"shares_display":"19,116","price_per_share":0.6185,"price_display":"0.62","price_state":"stated","total_value":11823.246,"total_display":"11,823.25","shares_owned_after":11850809.0,"shares_owned_after_display":"11,850,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-22","filed_date":"2012-03-23","scope":"insider"},{"id":2494761,"accession":"0001179110-12-005657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-005657","line_url":"/filing/0001179110-12-005657#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30884.0,"shares_display":"30,884","price_per_share":0.617,"price_display":"0.62","price_state":"stated","total_value":19055.428,"total_display":"19,055.43","shares_owned_after":11831693.0,"shares_owned_after_display":"11,831,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-21","filed_date":"2012-03-23","scope":"insider"},{"id":8819621,"accession":"0001179110-11-013861","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-013861","line_url":"/filing/0001179110-11-013861#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":14000.0,"total_display":"14,000.00","shares_owned_after":11937609.0,"shares_owned_after_display":"11,937,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-30","filed_date":"2011-10-04","scope":"insider"},{"id":9130829,"accession":"0001179110-11-012933","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-012933","line_url":"/filing/0001179110-11-012933#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":6900.0,"total_display":"6,900.00","shares_owned_after":11912609.0,"shares_owned_after_display":"11,912,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-02","filed_date":"2011-09-06","scope":"insider"},{"id":9130828,"accession":"0001179110-11-012933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-012933","line_url":"/filing/0001179110-11-012933#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31887.0,"shares_display":"31,887","price_per_share":0.704,"price_display":"0.70","price_state":"stated","total_value":22448.448,"total_display":"22,448.45","shares_owned_after":11902609.0,"shares_owned_after_display":"11,902,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-06","scope":"insider"},{"id":8923276,"accession":"0001179110-11-012705","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-012705","line_url":"/filing/0001179110-11-012705#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11871.0,"shares_display":"11,871","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":7834.86,"total_display":"7,834.86","shares_owned_after":38530.0,"shares_owned_after_display":"38,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-26","filed_date":"2011-08-29","scope":"insider"},{"id":8923274,"accession":"0001179110-11-012705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-012705","line_url":"/filing/0001179110-11-012705#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":2970.0,"total_display":"2,970.00","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-26","filed_date":"2011-08-29","scope":"insider"},{"id":8923271,"accession":"0001179110-11-012705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-012705","line_url":"/filing/0001179110-11-012705#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3650.0,"shares_display":"3,650","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":2409.0,"total_display":"2,409.00","shares_owned_after":38650.0,"shares_owned_after_display":"38,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-26","filed_date":"2011-08-29","scope":"insider"},{"id":8861396,"accession":"0001179110-11-012629","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-11-012629","line_url":"/filing/0001179110-11-012629#line-4","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.666,"price_display":"0.67","price_state":"stated","total_value":23310.0,"total_display":"23,310.00","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-24","filed_date":"2011-08-25","scope":"insider"},{"id":8861395,"accession":"0001179110-11-012629","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-012629","line_url":"/filing/0001179110-11-012629#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26659.0,"shares_display":"26,659","price_per_share":0.666,"price_display":"0.67","price_state":"stated","total_value":17754.894,"total_display":"17,754.89","shares_owned_after":26659.0,"shares_owned_after_display":"26,659","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-24","filed_date":"2011-08-25","scope":"insider"},{"id":8861393,"accession":"0001179110-11-012629","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-012629","line_url":"/filing/0001179110-11-012629#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.6553,"price_display":"0.66","price_state":"stated","total_value":9829.5,"total_display":"9,829.50","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-24","filed_date":"2011-08-25","scope":"insider"},{"id":8861391,"accession":"0001179110-11-012629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-012629","line_url":"/filing/0001179110-11-012629#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.6464,"price_display":"0.65","price_state":"stated","total_value":12928.0,"total_display":"12,928.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-23","filed_date":"2011-08-25","scope":"insider"},{"id":9241822,"accession":"0001179110-11-010084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-010084","line_url":"/filing/0001179110-11-010084#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21900.0,"shares_display":"21,900","price_per_share":0.625,"price_display":"0.62","price_state":"stated","total_value":13687.5,"total_display":"13,687.50","shares_owned_after":11894622.0,"shares_owned_after_display":"11,894,622","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-24","scope":"insider"},{"id":9241821,"accession":"0001179110-11-010084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-010084","line_url":"/filing/0001179110-11-010084#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27450.0,"shares_display":"27,450","price_per_share":0.625,"price_display":"0.62","price_state":"stated","total_value":17156.25,"total_display":"17,156.25","shares_owned_after":11894622.0,"shares_owned_after_display":"11,894,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-24","scope":"insider"},{"id":8975115,"accession":"0001179110-11-009918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-009918","line_url":"/filing/0001179110-11-009918#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27450.0,"shares_display":"27,450","price_per_share":0.625,"price_display":"0.62","price_state":"stated","total_value":17156.25,"total_display":"17,156.25","shares_owned_after":15433202.0,"shares_owned_after_display":"15,433,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-20","scope":"insider"},{"id":8975114,"accession":"0001179110-11-009918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-009918","line_url":"/filing/0001179110-11-009918#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464549","owner_name":"Kim Jong Joseph","owner_url":"/insider/0001464549","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21900.0,"shares_display":"21,900","price_per_share":0.625,"price_display":"0.62","price_state":"stated","total_value":13687.5,"total_display":"13,687.50","shares_owned_after":15433202.0,"shares_owned_after_display":"15,433,202","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001055726","name":"INOVIO PHARMACEUTICALS, INC.","url":"/issuer/0001055726","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":23,"first_seen":"2011-06-20","last_seen":"2021-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001464549","retrieved_at":"2026-08-21T06:46:15+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}